New Jersey Better Educational Savings Trust Ligand Pharmaceuticals Inc Transaction History

New Jersey Better Educational Savings Trust

  • $52 Million
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 31, 2020
SELL
$96.94 - $113.59 $232,656 - $272,616
-2,400 Closed
0 $0
Q1 2019

May 01, 2019
BUY
$105.93 - $142.47 $254,232 - $341,928
2,400 New
2,400 $302,000

Others Institutions Holding LGND

# of Institutions
275
Shares Held
18.5M
Call Options Held
30.8K
Put Options Held
5.2K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.98B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track New Jersey Better Educational Savings Trust Portfolio

Follow New Jersey Better Educational Savings Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Jersey Better Educational Savings Trust, based on Form 13F filings with the SEC.

News

Stay updated on New Jersey Better Educational Savings Trust with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email